Back to search

Heart Biotech Nano Limited

09309176

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk

No risk factors detected.

Details

17 NORTH DRIVE, WINCHESTER, SO22 6QA
Incorporated 13/11/2014

Compliance

Last accounts

30/09/2025

total exemption full

Next accounts due

30/06/2027

On track

Confirmation statement

Last: 13/11/2025

Due 27/11/2026

On track

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Dr Magdy Adib Ishak-Hanna

director · Since 13/11/2014

DIRECTOR

BRITISH · ENGLAND · Age 78

Also on 10 other boards

Mr Samer Said Khouri

director · Since 13/11/2014

CIVIL ENGINEER

LEBANESE · LEBANON · Age 66

Also on 1 other board

Mr Mark Christopher Radford

director · Since 13/11/2014

DIRECTOR

BRITISH · UNITED KINGDOM · Age 62

Also on 7 other boards

Mr Ian Ashley Richardson

director · Since 13/11/2014

SOLICITOR

ENGLISH · ENGLAND · Age 67

Also on 6 other boards

Professor Sir Magdi Habib Yacoub

director · Since 13/11/2014

CLINCIAN / SCIENTIST

BRITISH · ENGLAND · Age 90

Also on 8 other boards

Mr Francis William White

director · Since 02/10/2024

CEO

BRITISH · ENGLAND · Age 59

Also on 7 other boards

Persons with Significant Control

Heart Biotech Holdings Limited

75–100% shares

1st Floor, 18, Hanover Street, London, W1S 1YN

Reg: 09001625 · England · Private Limited Company

Notified 06/04/2016

CompanyRankvs 4054+ SIC 72190 peers
46

Financial strength48th percentile among SIC peers · 12/25
Employees46th percentile among SIC peers · 7/15
LiquidityNo balance sheet data · 0/20
Longevity12 years trading (max 15) · 12/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Kemet International Limited
90
2R.B. Radley & Company Limited
90
3Sra Developments Limited
90
4Drumgrange Limited
90
5Giro Engineering Limited
90
6Hydronix Limited
90
7Fluid Gravity Engineering Limited
90
8Innovative Technology Limited
90
9Scanna Msc Limited
90
10Euclid Limited
90
4054Heart Biotech Nano Limited
45
How is this score calculated?
Financial strength12/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity12/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/09/2025

Net Worth

£113

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

-£883k

Working capital

Current Assets

—

Current Liabilities

£1.1M

Fixed Assets

£11k

Debtors

£241k

1avg. employees+1

Balance Sheet

Assets less current liabilities-£872k
Prepared with IRIS Accounts Production